U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Bumetanide Injection
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Fresenius Kabi USA, LLC (Revised 05/08/2026)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) Available Check wholesalers for inventory
Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 05/12/2026)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

MSN Laboratories Private Limited (Reverified 04/02/2026)

Company Contact Information:
Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) Available
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-101-07) Available
Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01) Available
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07) Available

Mullan Pharmaceutical Inc. (Revised 04/08/2026)

Company Contact Information:
800-673-9839

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2) Available
Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2) Limited Availability Additional lots are currently in the manufacturing process and will be available upon release. Demand increase for the drug

Sagent Pharmaceuticals (Reverified 04/23/2026)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04) Limited Availability Product in transit, expected to arrive last week of April 2026 Demand increase for the drug
Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10) Limited Availability Product in transit, expected to arrive last week of April 2026 Demand increase for the drug
Back to Top